The international sector for Active Pharmaceutical Ingredient (API) suppliers is a complex landscape, encompassing numerous locations. PRC currently holds the production of APIs, second to India, which is a significant player in both off-patent API distribution. European businesses, particularly in countries like Germany, Switzerland, and Italy, ma